Metastatic carcinoma to subcutaneous tissue and skeletal muscle: clinicopathological features in 11 cases.
OBJECTIVE
Metastatic carcinoma to subcutaneous tissue or skeletal muscle is relatively rare. The present study aimed to clarify the clinicopathological features for confirming the diagnosis as soft tissue metastasis and determining the primary site.


METHODS
We reviewed records of 11 patients with soft tissue metastasis who were in our institution from 1996 to 2009.


RESULTS
In 9 of 10 patients who underwent magnetic resonance imaging, findings consisted of poorly circumscribed high-intensity lesions around the tumor on T2-weighted images, irregular peritumoral enhancement and poorly enhanced lesions at the center of the tumor on T1-weighted images. Systematic immunohistochemical examination was more valuable for diagnosing as soft tissue metastasis and confirming the primary site. The expression patterns of cytokeratins 7 and 20 and tissue-specific antibodies such as thyroid transcription factor-1, MUC5AC and CDX2 were useful diagnostic markers. The primary site could be determined in five patients with cytokeratin 7/20 immunophenotype and positivity for tissue-specific antibodies. In four cases, determination of the primary site finally became possible by comparison with the histological findings of operative specimens in past carcinoma and/or in consideration of radiological findings and the results of cytokeratin 7/20 phenotyping.


CONCLUSIONS
Systematic immunohistochemical examination is helpful for confirmation of the primary origin in soft tissue metastasis of carcinoma in addition to clinical information such as the history and condition of past carcinoma, radiological findings and comparison between the histology of biopsy specimens and past carcinoma.
Department of Orthopaedic Surgery, Matsumoto, Nagano 390-8621, Japan. yyoshim@shinshu-u.ac.jp
Yasuo
Y
Yoshimura
Ken-ichi
K
Isobe
Tsuyoshi
T
Koike
Hideki
H
Arai
Kaoru
K
Aoki
Hiroyuki
H
Kato
D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D019042:Muscle Neoplasms / Q000556:secondary*; D018482:Muscle, Skeletal / Q000473:pathology*; D009367:Neoplasm Staging; D009369:Neoplasms / Q000473:pathology*; D011379:Prognosis; D012189:Retrospective Studies; D012983:Soft Tissue Neoplasms / Q000556:secondary*; D040521:Subcutaneous Tissue / Q000473:pathology*